n,n-dimethylarginine has been researched along with avapro in 2 studies
| Studies (n,n-dimethylarginine) | Trials (n,n-dimethylarginine) | Recent Studies (post-2010) (n,n-dimethylarginine) | Studies (avapro) | Trials (avapro) | Recent Studies (post-2010) (avapro) |
|---|---|---|---|---|---|
| 2,216 | 228 | 1,221 | 1,369 | 385 | 495 |
| Protein | Taxonomy | n,n-dimethylarginine (IC50) | avapro (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 7.3067 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0099 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.003 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baylis, C; Chen, GF; Moningka, NC; Sasser, JM; Wagner, L; Zharikov, S | 1 |
| Fukami, K; Ishibashi, Y; Matsui, T; Okuda, S; Ueda, S; Yamagishi, S | 1 |
2 other study(ies) available for n,n-dimethylarginine and avapro
| Article | Year |
|---|---|
Effects of angiotensin type 1 receptor blockade on arginine and ADMA synthesis and metabolic pathways in fawn-hooded hypertensive rats.
Topics: Amidohydrolases; Angiotensin II Type 1 Receptor Blockers; Animals; Arginine; Biphenyl Compounds; Citrulline; Hypertension; Irbesartan; Male; Metabolic Networks and Pathways; Nitric Oxide; Rats; Tetrazoles | 2010 |
Irbesartan inhibits advanced glycation end product-induced increase in asymmetric dimethylarginine level in mesangial cells through its anti-oxidative properties.
Topics: Antioxidants; Arginine; Biphenyl Compounds; Cells, Cultured; Glycation End Products, Advanced; Humans; Irbesartan; Mesangial Cells; Tetrazoles | 2014 |